Safety and efficacy of a pneumococcal vaccine in young kids
Part of Ear, nose & throat clinical trials.
This study tests a new pneumococcal vaccine (wSp) in young children who have already had 3 doses of a standard pneumococcal shot. It aims to see if the new vaccine is safe and works well to protect against serious infections.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child must be 6 months old (give or take about 2 months).
- Your child should be generally healthy with no known immune problems.
- Your child must have had 3 doses of a pneumococcal shot (PCV15 or PCV20).
- You must be willing to bring your child to every study visit and sign a consent form.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests an experimental pneumococcal vaccine in healthy infants. It involves three shots during infancy and a booster around 12-15 months to see if it is safe and how the body responds.
This study tests whether a new pneumococcal vaccine (which protects against a serious bacterial infection) is safe in healthy 2-month-old infants. Researchers will watch for side effects and help protect future babies from pneumococcal disease.
This study tests a new pneumococcal vaccine (PCV26) for safety in adults 60 and older. It aims to find out if the vaccine is safe and how the body responds to it.
This trial tests a new pneumococcal vaccine as a booster shot in toddlers who already got a full primary series. It aims to see if the booster is safe and produces a strong immune response.
This trial tests a new vaccine designed to protect against 24 types of pneumococcal bacteria (which cause pneumonia and other serious infections). Researchers are checking if it's safe and how well it works in infants, children, and adults.
This study tests an investigational vaccine that may protect infants against infections caused by a bacteria called Streptococcus pneumoniae, which can cause pneumonia and other serious illnesses. The vaccine is given to healthy babies around 2 months old, and the study will see how well it works and how safe it is.
Hear when a new Acute Otitis Media (AOM) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.